Asthma in the elite athlete
|
|
- Ashlee Charles
- 7 years ago
- Views:
Transcription
1 Asthma in the elite athlete Sergio Bonini Professor of Medicine Second University of Naples, Italy Dubai. December 5,2010
2 Prevalence of asthma among summer sports athletes
3 Prevalence of asthma among winter sports athletes
4 The Olympic study 21,6% 10,9% 21.6% 10.9% n = 265 n = 373
5 Allergy is a risk factor for EIA and EIB, particularly in athletes When allergy and intense exercise are combined, the risk of asthma is increased by : 25 folds in speed and power athletes 42 folds in endurance athletes 97 folds in swimmers from Helenius and Haahtela
6 Why asthma is so frequent in elite athletes? Effects of intense exercise on allergy Effects of intense exercise on the airways
7 Why asthma is so frequent in elite athletes? Effects of intense exercise on allergy Effects of intense exercise on the airways
8 Effect of intense and prolonged physical exercise on allergy Th2 Th1 Increased Th1 susceptibility to infections Th1 Increased Th2 prevalence Th2 Th2 Th2 of allergy and asthma
9 The GA2LEN Olympic Study Parameters Para-Olympics Olympics Pre-Olympics No. of athletes (347) 228 Questionnaires t.b.d SPT PFT n.a Mannitol Sera
10 The increasing prevalence of Allergy and Asthma in Athletes Bonini M. et al. The Ga2len Olympic Study Sensitization 32.6% Sensitization 56.5% in 84.4 % to multiple allergens
11 Allergens responsible for sensitisation 35 Any Sensitisation (1) Dermatophagoides pteronyssinus (2) Grasses (2) Cat dander (2) Olive tree (2) Pellitory (2) 10 5 Alternaria tenuis (2) Wormwood (2) Ragweed (2) 0 (1) % of athletes, (2) % of positive skin tests
12 Infectious diseases AIDA study: Allergy and Infectious Diseases in Athletes 265 pre-olympic athletes 3 or more than 3 URTI episodes in the last 12 months in 15.9% More than 1 Herpes labialis episode in the last 12 months in 12.1% Decreased number of CD3+ lymphocytes in 17.0% of athletes with a preferential reduction of CD4+ subpopulation (40,7+/-8,2), well related to clinical picture AIDA Study Group J Allegy Clin Immunol 2003;111:S142
13 Cytokine AA vs CTRL ANA vs CTRL A vs CTRL AA vs ANA IL-1ra <0,0001 <0,0001 < 0,0001 NS (0,9280) IL-6 < 0,0001 0,0005 < 0,0001 NS (0,1882) IL-7 0,0001 < 0,0001 < 0,0001 NS (0,3663) IL-8 < 0,0001 < 0,0001 < 0,0001 NS (0,9875) IL-12 < 0,0001 < 0,0001 < 0,0001 NS (0,9093) IL-10 0,0002 0,0011 < 0,0001 NS (0,1366) IL-13 NS (0,2450) NS (0,2236) NS (0,1659) NS (0,9436) IL-17 0,0002 0,0008 < 0,0001 NS (0,3984) Eotaxin < 0,0001 < 0,0001 < 0,0001 NS (0,9749) Cytokine and in Allergic Growth Factor Serum Profile and Non- Allergic Top Atletes AA = 41; ANA = 51; CTRL = 49; Luminex assay For all cytokines measured, apart from IL-13, TNFa and MIP-1a, serum levels in athletes were significantly lower than in controls. IFN-gamma < 0,0001 < 0,0001 < 0,0001 NS (0,8752) IP-10 < 0,0001 0,0004 < 0,0001 NS (0,5584) MCP-1 < 0,0001 < 0,0001 < 0,0001 NS (0,5427) MIP-1alfa NS (0,1298) NS (0,1467) NS (0,0852) NS (0,9187) MIP-1beta < 0,0001 < 0,0001 < 0,0001 NS (0,2979) RANTES 0,0141 0,0274 < 0,05 NS (0,8690) TNF-alfa NS (0,2048) NS (0,5124) NS (0,2762) NS (0,4579) Abs. submitted to the AAAAI 2011 Congress
14 NGF serum levels in elite athletes ± Measured in... athletes trough a Means ± ±483.7 double-antibody ELISA pg/ml pg/ml pg/ml AA + AnA vs HC P< AA NAA Non allergic HC athletes n = 52 Allergic athletes n = 44 Healthy controls n = 49
15 Why asthma is so frequent in elite athletes? Effects of intense exercise on allergy Effects of intense exercise on the airways
16 Physical exercise as a trigger on airways Increased ventilation Nasal filter by-pass Climate condition (cold-dry air) Exposure to indoor and outdoor allergens Exposure to pollutants (O3, PM2.5-10, NO2, SO2) Exposure to irritants (chlorine)
17 Physical exercise
18 Working definitions of Exercise-Induced Asthma (EIA) and Exercise-Induced Brochospasm (EIB) EIA: the condition in which exercise induces symptoms of asthma in patients who have asthma EIB: the airways obstruction that occurs in association with exercise without regard to the presence of chronic asthma Weiler JM, Bonini S, Coifman R, et al. J Allergy Clin Immunol 2007; 119:
19 Prevalence of EIB in Athletes Swimmers Controls Zwick et al., Lung 1990; 168: Potts, Sports Med 1996; 21: % 36% 60% 12%
20 EIB in Athletes Higher prevalence than in other populations Reported and objectively assessed in a higher number of athletes than those with clinical asthma, particularly in winter sports Peculiar mechanisms (osmotic, thermal and mechanical) linked to hyperpnea. Often associated with neutrophilic rather than eosinophilic inflammation. Epithelial damage? Autonomic deregulation? Poorly predicted by baseline pulmonary function tests More frequently associated with a positive indirect provocation test (office or field exercise, eucapnic voluntary hyperventilation, mannitol, etc.) than with direct provocation tests (methacholine, histamine) Less responsive to inhaled corticosteroids than EIA.
21 Diagnosis of Asthma and EIB in Athletes
22
23 AQUA (Methodology) Derived from the ECRHS questionnaire On the basis of interviews with team doctors, coaches and athletes specific questions were added Preliminary administration to verify comprehensiveness and reproducibility Administration to 128 professional soccer players of 6 elite teams Validation against documented clinical allergy (Anamnesis, OE, Skin-prick-test and/or Phadiatop) Key-questions scored from 1 to 5 on the basis of their positive likelihood ratio
24 AQUA (Results) A total score > 5 showed the best positive predictive value for allergy (0.93) with a specificity of 97.1% and a sensitivity of 58.3%. The questionnaire, translated in 10 languages was used in the framework of the GA2LEN Olympic Study The questionnaire, protected by copyright, is available on request (free for non commercial use)
25 Bonini M. et al. Allergy 2007; 62:
26 Provocative challenges Direct Methacoline challenge Histamine challenge Indirect Exercise challenge On the field Free running athletic screening test FRAST Specific sport challenge (appropriate for elite athletes) In the laboratory Treadmill Cycle ergometer Eucapnic voluntary hyperpnea Mannitol challenge
27 2011 WADA antidoping rules Treatment WADA rules Notes Antihistamines Leukotriene modifiers Inhaled steroids Oral steroids Inhaled b2 agonists Salbutamol (max 1600 mcg/24h) Salmeterol Oral β2 agonists Ephedrine, methylephedrine Permitted Permitted Permitted And do not require any more a Declaration of Use Prohibited in competition (Do not require any more a Declaration of Use) Prohibited in and out competition Prohibited in competition Second generation molecules should be preferred to avoid side effects Topical preparations for dermatological, auricolar, nasal, buccal, ophtalmic use are not prohibited A concentration of salbutamol greater than 1000 ng/ml is considered an adverse analytical finding unless proven as due to therapeutic use A concentration in urine greater than 10 ug/ml represent an adverse analytical findings
28
29 EIB or not EIB? That is the question S.Bonini Med Sci Sports Exerc 2008;40:
30 IOC criteria for the diagnosis of asthma at the 2008 Beijing Olympic Games Diagnostic procedure Criteria Pulmonary function Bronchodilator test Eucapnic Voluntary Hyperpnea (EVH) FEV 1 <70%, FEV 1 /VC<55% FEV 1 12% e >200 ml FEV 1 10% Exercise challenge FEV 1 10% Methacoline challenge Hyperosmolar test (Mannitol, Saline) FEV 1 20% with a: PC 20 4 mg/ml (for subjects not taking ICS) or PC mg/ml (for subjects taking ICS for at least 1 month) FEV 1 15% To be allowed to use beta-2 agonists, a positive clinical history associated to at least one positive test is required.
31 Treatment of EIB The two main principles of treating exerciseinduced bronchospasm consist in: reversing the bronchial obstruction induced by exercise with bronchodilators preventing it either by the chronic use of controller drugs in subjects with asthma or by administering, just before exercise, drugs which have been shown to be able to inhibit symptoms as well as the decrease of pulmonary function parameters
32 The FDA and safe Use of Long-Acting Beta-Agonists in the treatment of Asthma Chowdhury BA and Dal Pan G New Engl J Med 2010;362:1-3 Specific Label Changes for Long-Acting Beta-Agonists (LABAs) 1. Contraindicate the use of LABAs for asthma in patients of allages without con-comitant use of an asthma-controller medication such as an inhaled cortico-steroid. 2. Stop use of the LABA, if possible, once asthma control is achieved and maintain the use of an asthma-controller medication, such as an inhaled corticosteroid. 3. Recommend against LABA use in patients whose asthma is adequately controlled with a low-or medium-dose inhaled corticosteroid. 4. Recommend that a fixed-dose combination product containing a LABA and an inhaled corticosteroid be used to ensure compliance with concomitant therapy in pediatric and adolescent patients who require the addition of a LABA to an inhaled corticosteroid.
33 Beta-2 agonist effects on physical performance Carlsen KH et al.
34 Do β2-agonists really enhance physical performance? An in vitro study on their effect on a skeletal muscle cell line B2-agonist effect on myogenin and myosin 3A myogenin mrna (arbitrary units) 3 2,5 2 1,5 1 0,5 5A MyHC slow MyHC fast α-tubulina 0 Untreated Formoterol Clenbuterol Salbutamol Salmeterol 3B myogenin α-tubulina 5B MyHC slow/αtubulin (arbitrary units) Untreated Clenbuterol Formoterol Salbutamol Salmeterol 3C myogenin/αtubulin (arbitrary units) Untreated Clenbuterol Formoterol Salbutamol Salmeterol 5C MyHC fast/α /αtubulin (arbitrary units) Untreated Clenbuterol Formoterol Salbutamol Salmeterol
35 Do β2-agonists really enhance physical performance? An in vitro study on their effect on a skeletal muscle cell line Results: B2-agonist effect on atrophy markers 6A 9 Atrogin 6B 2,5 Murf1 mrna (arbitrary units) ** mrna (arbitrary units) 2 1,5 1 0,5 ** 1 0 Untreated Formoterol Clenbuterol Salbutamol Salmeterol 0 Untreated Formoterol Clenbuterol Salbutamol Salmeterol 6 6C Catepsin L mrna (arbitrary units) ** Untreated Formoterol Clenbuterol Salbutamol Salmeterol **: p<0,001
36 Beta-2 agonist cardiovascular side effects
37
38
39
40
41
42 Bronchoprotection (Average max % FEV 1 fall at baseline max % fall FEV 1 after salmeterol) Average max % FEV 1 fall at baseline Mean BP: 65.1% Mean BP: 3.1% % Bronchoprotection Mean LOB: 95.2% Bonini M. Data presented at the 2010 ATS Congress
43 . and in the real life? Italian top Olympic athlete with a history of severe persistent rhinitis and mild intermittent asthma Negative physical examination Sensitization to Der.pt., Parietaria, Grass FEV1 110% ; FVC 107% : MMEF50% 104% Salbutamol test : 8% ; Exercise test : -18% Treatment : High doses of Bud/Form plus Salmeterol before exercise!
44 The elite athlete: Yes, with allergy we can S.Bonini, T.Craig J Allergy Clin Immunol 2008;122:249-50
adrenoceptor agonists and the Olympic Games in Turin
Beta 2 adrenoceptor agonists and the Olympic Games in Turin 1. INTRODUCTION Article 4 of the World Anti-Doping Code refers to the Prohibited List as the international standard. This List, which came into
More informationTests. Pulmonary Functions
Pulmonary Functions Tests Static lung functions volumes Dynamic lung functions volume and velocity Dynamic Tests Velocity dependent on Airway resistance Resistance of lung tissue to change in shape Dynamic
More informationASTHMA IN INFANTS AND YOUNG CHILDREN
ASTHMA IN INFANTS AND YOUNG CHILDREN What is Asthma? Asthma is a chronic inflammatory disease of the airways. Symptoms of asthma are variable. That means that they can be mild to severe, intermittent to
More informationPATIENT INFORMATION ABOUT TREATMENTS FOR ASTHMA AND ALLERGIC RHINITIS, PRESCRIPTIONS & OVER THE COUNTER MEDICINE
PATIENT INFORMATION ABOUT TREATMENTS FOR ASTHMA AND ALLERGIC RHINITIS, PRESCRIPTIONS & OVER THE COUNTER MEDICINE The content of this booklet was developed by Allergy UK. MSD reviewed this booklet to comment
More informationClassifying Asthma Severity and Initiating Treatment in Children 0 4 Years of Age
Classifying Asthma Severity and Initiating Treatment in Children 0 4 Years of Age Components of Severity Symptoms Intermittent 2 days/week Classification of Asthma Severity (0 4 years of age) Persistent
More informationDiagnosis and treatment of asthma in athletes
Mariana Couto 1,2, André Moreira 1,2,3, Luís Delgado 1,2,3 1 Allergy, Asthma & Sports Unit, Immunoallergology Department, Centro Hospitalar São João EPE 2 Immunology Department, Faculty of Medicine, University
More informationProf. Florian Gantner. Vice President Respiratory Diseases Research Boehringer Ingelheim
Prof. Florian Gantner Vice President Respiratory Diseases Research Boehringer Ingelheim Research and Development in Practice: COPD Chronic Obstructive Pulmonary Disease (COPD) Facts Main cause of COPD
More informationCompare the physiologic responses of the respiratory system to emphysema, chronic bronchitis, and asthma
Chapter 31 Drugs Used to Treat Lower Respiratory Disease Learning Objectives Describe the physiology of respirations Compare the physiologic responses of the respiratory system to emphysema, chronic bronchitis,
More informationExercise-Induced Bronchospasm* Coding and Billing for Physician Services
CHEST Topics in Practice Management Exercise-Induced Bronchospasm* Coding and Billing for Physician Services Carol Pohlig, BSN, RN Physician reporting of the service to insurance companies for reimbursement
More informationMILITARY (ACTIVE DUTY)-SPECIFIC ISSUES
RECOMMENDATIONS MILITARY (ACTIVE DUTY)-SPECIFIC ISSUES Evaluation for possible asthma 1. Active duty service members should be diagnosed with asthma or exerciseinduced bronchospasm on the basis of the
More informationTreatment of Asthma. Talk to your doctor about the various medications available to treat asthma.
Please call 911 if you think you have a medical emergency. Treatment of Asthma The goals of asthma therapy are to prevent your child from having chronic and troublesome symptoms, to maintain your child's
More information"Respiratory Problems in Swimmers: How to keep Swimmers Afloat" and in the Pool!
"Respiratory Problems in Swimmers: How to keep Swimmers Afloat" and in the Pool! Charles Siegel, MD Associate Clinical Professor University of Missouri @ Kansas City School of Medicine USA Swimming does
More informationunderstanding the professional guidelines
SEVERE ASTHMA understanding the professional guidelines This guide includes information on what the European Respiratory Society (ERS) and the American Thoracic Society (ATS) have said about severe asthma.
More informationFrequent co-morbid conditions with asthma. Nelson Rosário MD, PhD, FAAAAI, FACAAI
Frequent co-morbid conditions with asthma Nelson Rosário MD, PhD, FAAAAI, FACAAI Comorbidities in childhood asthma Knowledge is sparse. Further studies are needed: to identify the prevalence the effects
More informationThe Right Medicines Can Help You Get Control of Asthma. BlueCare SM TennCareSelect
The Right Medicines Can Help You Get Control of Asthma BlueCare SM TennCareSelect WHEEZING. COUGHING. SHORTNESS OF BREATH. CHEST TIGHTNESS. If you or a family member has asthma, you know these symptoms
More informationmedicineupdate to find out more about this medicine
medicineupdate Asking the right questions about new medicines Seretide for chronic obstructive pulmonary disease What this medicine is 1 What this medicine treats 2 Other medicines available for this condition
More informationUpdate on Exercise-Induced Asthma
Università di Cagliari Update on Exercise-Induced Asthma Dr. Stefano Del Giacco, MD Professor of Internal & Sports Medicine University of Cagliari, Italy stedg@medicina.unica.it Treating asthma and allergy
More informationSevere asthma Definition, epidemiology and risk factors. Mina Gaga Athens Chest Hospital
Severe asthma Definition, epidemiology and risk factors Mina Gaga Athens Chest Hospital Difficult asthma Defined as asthma, poorly controlled in terms of chronic symptoms, with episodic exacerbations,
More informationAustralian Association for Exercise and Sports Science position statement on exercise and asthma
Available online at www.sciencedirect.com Journal of Science and Medicine in Sport 14 (2011) 312 316 Review Australian Association for Exercise and Sports Science position statement on exercise and asthma
More informationAsthma. Micah Long, MD
Asthma Micah Long, MD Goals Define the two components of asthma. Describe the method of action and uses for: Steroids (inhaled and IV) Quick Beta Agonists (Nebs and MDIs) The "Others" Magnesium, Epi IM,
More informationDrug therapy SHORT-ACTING BETA AGONISTS SHORT-ACTING ANTICHOLINERGICS LONG-ACTING BETA AGONISTS LONG-ACTING ANTICHOLINERGICS
Drug therapy 6 6.1 What is the role of bronchodilators in COPD? 52 SHORT-ACTING BETA AGONISTS 6.2 How do short-acting beta agonists work? 52 6.3 What are the indications for their use? 52 6.4 What is the
More informationGuidance to support the stepwise review of combination inhaled corticosteroid therapy for adults ( 18yrs) in asthma
Guidance to support the stepwise review of combination inhaled corticosteroid therapy for adults ( 18yrs) in asthma Important Complete asthma control needs to be achieved for at least 12 weeks before attempting
More informationHow to use FENO-guided asthma control in routine clinical practice
How to use FENO-guided asthma control in routine clinical practice Asthma is a chronic inflammatory disease of the airways. This has implications for the diagnosis, management and potential prevention
More informationII. ASTHMA BASICS. Overview of Asthma. Why do I need to know about asthma?
II. ASTHMA BASICS Overview of Asthma Why do I need to know about asthma? In the United States, asthma is the most common chronic childhood illness. Asthma affects an estimated 4.8 million children nationally,
More informationAn Overview of Asthma - Diagnosis and Treatment
An Overview of Asthma - Diagnosis and Treatment Asthma is a common chronic disorder of the airways that is complex and characterized by variable and recurring symptoms, airflow obstruction, bronchial hyperresponsiveness,
More information9/16/2014. Anti-Immunoglobulin E (IgE) Omalizumab (Xolair ) Dosing Guidance
Disclosure Statement of Financial Interest New Therapies for Asthma Including Omalizumab and Anti-Cytokine Therapies Marsha Dangler, PharmD, BCACP Clinical Pharmacy Specialist James H. Quillen VA Medical
More informationThe Annual Direct Care of Asthma
The Annual Direct Care of Asthma The annual direct health care cost of asthma in the United States is approximately $11.5 billion; indirect costs (e.g. lost productivity) add another $4.6 billion for a
More informationObjectives. Asthma Management
Objectives Asthma Management BREATHE Conference Allergy and Asthma Specialists PC Christine Malloy MD March 22, 2013 Review the role of inflammation in asthma Discuss the components of the EPR-3 management
More informationDRUG UTILISATION STUDY IN BRONCHIAL ASTHMA IN A TERTIARY CARE HOSPITAL
International Journal of Pharmaceutical Applications ISSN 0976-2639, Online ISSN 2278 6023 Vol 3, Issue 2, 2012, pp 297-305 http://www.bipublication.com DRUG UTILISATION STUDY IN BRONCHIAL ASTHMA IN A
More informationAsthma (With a little SCID to start) Disclosures Outline Starting with the Immune System The Innate Immune System The Adaptive Immune System
1 2 3 4 5 6 7 8 9 Asthma (With a little SCID to start) Lauren Smith, MD CHKD Pediatric Allergy/Immunology Disclosures None Will be discussing some medications that are not yet FDA approved Outline SCID
More informationBackground information
Background information Asthma Asthma is a complex disease affecting the lungs that can be managed but cannot be cured. 1 Asthma can be controlled well in most people most of the time, although some people
More informationBreathe Easy: Asthma and FMLA
This article was published in the FMLA Policy, Practice, and Legal Update newsletter, by Business & Legal Reports, Inc. (BLR). BLR is a nationally recognized publisher of regulatory and legal compliance
More informationBronchodilators in COPD
TSANZSRS Gold Coast 2015 Can average outcomes in COPD clinical trials guide treatment strategies? Long live the FEV1? Christine McDonald Dept of Respiratory and Sleep Medicine Austin Health Institute for
More informationGuideline on the clinical investigation of medicinal products for the treatment of asthma
22 October 2015 CHMP/EWP/2922/01 Rev.1 Committee for Medicinal Products for Human Use (CHMP) Guideline on the clinical investigation of medicinal products for the treatment of Draft Agreed by Respiratory
More informationSeasonal Allergies. 1995-2012 The Patient Education Institute, Inc. www.x-plain.com im010101 Last reviewed: 05/30/2012 1
Seasonal Allergies Introduction Seasonal allergies are allergies that develop during certain times of the year. Seasonal allergies are usually a response to pollen from trees, grasses, and weeds. Constant
More informationASTHMA< Observation about treatment and education of patients in San Pablo Clinic, Heredia Costa Rica
ASTHMA< Observation about treatment and education of patients in San Pablo Clinic, Heredia Costa Rica Rachel Borovina, MSIV Lisa Troeger, MSIV University of California San Francisco IHCAI FOUNDATION 2001
More informationInformation for Behavioral Health Providers in Primary Care. Asthma
What is Asthma? Information for Behavioral Health Providers in Primary Care Asthma Asthma (AZ-ma) is a chronic (long-term) lung disease that inflames and narrows the airways. Asthma causes recurring periods
More informationVirginia Tech Departmental Policy 27 Sports Medicine Key Function:
Virginia Tech Departmental Policy 27 Sports Medicine Key Function: Review: Yearly Director of Athletic Training Title: Management of Asthma in Athletes Section: Treatment S-A Safety POLICY STATEMENT: This
More informationAllergy Testing Test Request and Result Interpretation. Learning Objectives
Allergy Testing Test Request and Result Interpretation Dr. Kareena Schnabl, MSc, PhD, FCACB Clinical Biochemist, Genetic Laboratory Services University of Alberta Hospital Newborn Screening & Biochemical
More informationCOPD and Asthma Differential Diagnosis
COPD and Asthma Differential Diagnosis Chronic Obstructive Pulmonary Disease (COPD) is the third leading cause of death in America. Learning Objectives Use tools to effectively diagnose chronic obstructive
More informationOn completion of this chapter you should be able to: discuss the stepwise approach to the pharmacological management of asthma in children
7 Asthma Asthma is a common disease in children and its incidence has been increasing in recent years. Between 10-15% of children have been diagnosed with asthma. It is therefore a condition that pharmacists
More informationYOU VE BEEN REFERRED TO AN ASTHMA SPECIALIST...
YOU VE BEEN REFERRED TO AN ASTHMA SPECIALIST... ...HERE S WHAT TO EXPECT You have been referred to an allergist because you have or may have asthma. The health professional who referred you wants you to
More informationMedicines Use Review Supporting Information for Asthma Patients
Medicines Use Review Supporting Information for Asthma Patients What is asthma? Asthma is a chronic inflammatory disorder of the airways. The inflammation causes an associated increase in airway hyper-responsiveness,
More informationCOPD PROTOCOL CELLO. Leiden
COPD PROTOCOL CELLO Leiden May 2011 1 Introduction This protocol includes an explanation of the clinical picture, diagnosis, objectives and medication of COPD. The Cello way of working can be viewed on
More informationSponsor Novartis Pharmaceuticals
Clinical Trial Results Database Page 1 Sponsor Novartis Pharmaceuticals Generic Drug Name Indacaterol Therapeutic Area of Trial Chronic Obstructive Pulmonary Disease (COPD) Indication studied: COPD Study
More informationManagement of Asthma
Federal Bureau of Prisons Clinical Practice Guidelines May 2013 Clinical guidelines are made available to the public for informational purposes only. The Federal Bureau of Prisons (BOP) does not warrant
More informationSome Historical Perspective
BREAKING THROUGH ALL THE ACRONYMS CLEARING UP CONFUSING RESPIRATORY ISSUES IN ATHLETES Chris Koutures, MD, FAAP 8 th Annual Pediatric and Adolescent Sports Medicine Update Some Historical Perspective 1
More informationNote for guidance on clinical investigation of medicinal products for treatment of asthma
1 2 3 27 June 2013 CHMP/EWP/2922/01 Rev.1 Committee for Medicinal Products for Human Use (CHMP) 4 5 6 Note for guidance on clinical investigation of medicinal products for treatment of asthma Draft Draft
More informationFactors Associated with Underutilization of Inhalation Corticosteroids. among Asthmatic Patients Attending Tikur Anbessa Specialized Hospital
Factors Associated with Underutilization of Inhalation Corticosteroids among Asthmatic Patients Attending Tikur Anbessa Specialized Hospital By: Yohanes Ayele (B. Pharm) A thesis submitted to the School
More informationAnnotated from the NAEPP/NHLBI Updated Asthma Guidelines and Developed Through Expert Consensus
Asthma Pocket Guide for Primary Care Annotated from the NAEPP/NHLBI Updated Asthma Guidelines and Developed Through Expert Consensus POSITION STATEMENT Despite advances in therapy, asthma remains a disease
More informationACTIVITY #3: LUNG HEALTH ASTHMA AND ALLERGIES
ACTIVITY #3: LUNG HEALTH ASTHMA AND ALLERGIES TIME 50 minutes, computer lab REQUIRED RESOURCES Activity Computer lab with internet access for student research Notepaper and pencil for research Poster board
More informationStrategies for Improving Patient Outcomes in Pediatric Asthma Through Education. Pediatric Asthma. Epidemiology. Epidemiology
Strategies for Improving Patient Outcomes in Pediatric Asthma Through Education Chris Orelup, MS3 Max Project 3/1/01 Pediatric Asthma The leading cause of illness in childhood 10, 000, 000 school absences
More informationThe Proper Treatment Of Asthma
The Proper Treatment Of Asthma Southwest Allergy & Asthma Foundation Page 1 of 10 INTRODUCTION The purpose of this pamphlet is to supply information which will give patients suffering with asthma, an intelligent
More informationPre-Operative Services Teaching Rounds 2 Jan 2011
Pre-Operative Services Teaching Rounds 2 Jan 2011 Deborah Richman MBChB FFA(SA) Director Pre-Operative Services Department of Anesthesia Stony Brook University Medical Center, NY drichman@notes.cc.sunysb.edu
More informationObjectives COPD. Chronic Obstructive Pulmonary Disease (COPD) 4/19/2011
Objectives Discuss assessment findings and treatment for: Chronic Obstructive Pulmonary Disease Bronchitis Emphysema Asthma Anaphylaxis Other respiratory issues Provide some definitions Chronic Obstructive
More informationTable E1: Antibiotic use in infancy and wheeze and asthma: longitudinal studies until January 2010
Table E1: Antibiotic use in infancy and wheeze and asthma: longitudinal studies until January 2010 Mai 2010, Sweden [32] Dom 2010, Belgium [33] Su 2010, USA [34] Sobko 2010, Sweden [49] Schmitt 2009, Germany
More informationChronic obstructive pulmonary disease (COPD)
Chronic obstructive pulmonary disease (COPD) Chronic obstructive pulmonary disease (COPD) is the name for a group of lung diseases including chronic bronchitis, emphysema and chronic obstructive airways
More informationEVIDENCE-BASED BEST PRACTICES FOR THE MANAGEMENT OF ASTHMA IN PEDIATRIC PRIMARY CARE IN SOUTH CAROLINA
EVIDENCE-BASED BEST PRACTICES FOR THE MANAGEMENT OF ASTHMA IN PEDIATRIC PRIMARY CARE IN SOUTH CAROLINA Sarah Ball, PharmD Mike Bowman, MD Sandra Garner, PharmD Nancy Hahn, PharmD Sophie Robert, PharmD
More informationIn the last few decades, asthma has become epidemic. As the most common
Licensed School Nurse/ Public Health Nurse/ Registered Nurse In the last few decades, asthma has become epidemic. As the most common chronic childhood disease, asthma affects more than six million children
More informationA ragweed pollen as a treatment for a ragweed allergy? It s called immunotherapy.
A ragweed pollen as a treatment for a ragweed allergy? It s called immunotherapy. RAGWITEK is a prescription medicine used for sublingual (under the tongue) immunotherapy to treat ragweed pollen allergies
More informationExploratory data: COPD and blood eosinophils. David Price: 9.23-9.35am
Exploratory data: COPD and blood eosinophils David Price: 9.23-9.35am Blood Eosinophilia in COPD The reliability and utility of blood eosinophils as a marker of disease burden, healthcare resource utilisation
More informationTraining Manual & Speaker s Guide
Training Manual & Speaker s Guide Based on National Asthma Education and Prevention Program (NAEPP) Guidelines including the NAEPP s Guidelines Implementation Panel (GIP) Priority Messages. Funded in part
More informationMedical Policy An independent licensee of the Blue Cross Blue Shield Association
Afrezza Page 1 of 6 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: Afrezza (human insulin) Prime Therapeutics will review Prior Authorization requests Prior Authorization
More informationAsthma in Infancy, Childhood and Adolescence. Presented by Frederick Lloyd, MD Palo Alto Medical Foundation Palo Alto, California
Asthma in Infancy, Childhood and Adolescence Presented by Frederick Lloyd, MD Palo Alto Medical Foundation Palo Alto, California Major Health Problem in Childhood Afflicts 2.7 million children in the USA
More informationCOMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP)
European Medicines Agency Pre-authorisation Evaluation of Medicines for Human Use London, 22 January 2009 Doc. Ref. CPMP/EWP/4151/00 Rev. 1 COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) GUIDELINE
More informationThe patient s response to therapy within the first hour in the Emergency Room is one of the most reliable ways to predict need for hospitalization.
Emergency Room Asthma Management Algorithm The Emergency Room Asthma Management Algorithm is to be used for any patient seen in the Emergency Room with the diagnosis of asthma. (The initial history should
More informationMontelukast Sodium. -A new class of seasonal allergic rhinitis therapy
Montelukast Sodium -A new class of seasonal allergic rhinitis therapy Symptoms of Seasonal Allergic Rhinitis Nasal itch Sneezing Rhinorrhoea Nasal stuffiness Pathogenesis of Allergic Rhinitis Mast cells,
More informationPICO and search strategy worksheet 1
Start as you mean to go on, use the Cochrane Library and PICO search skills as soon as possible. The earlier you get used to doing them, the easier it becomes and you'll find you can easily tweak your
More informationFindings of corticosteroids in samples collected from Lance Armstrong during the 1999 Tour de France
Findings of corticosteroids in samples collected from Lance Armstrong during the 1999 Tour de France This document explains how the presence of corticosteroids (triamcinolone acetonide) in four urine samples
More informationAsthma: Practical Tips For Coaches. Developed by: The Minnesota Department of Health Asthma Program - updated 2008
Asthma: Practical Tips For Coaches Developed by: The Minnesota Department of Health Asthma Program - updated 2008 How Many Kids Have Asthma? Approximately 2.5 students in a class of 30 are likely to have
More informationDO YOU HAVE ITCHY ALLERGY EYES? Find out about lasting relief
DO YOU HAVE ITCHY ALLERGY EYES? Find out about lasting relief Common causes of itching due to eye allergies include: Pollen from trees, grasses, and ragweed Dust mites Cat dander Approximately 10 million
More informationDear Provider: Sincerely,
Asthma Toolkit Dear Provider: L.A. Care is pleased to present this updated asthma toolkit. Our goal is to promote the highest level of asthma care, based on the 2007 National Asthma Education and Prevention
More informationMontelukast 10mg film-coated tablets PL 17907/0474
Montelukast 10mg film-coated tablets PL 17907/0474 UKPAR TABLE OF CONTENTS Lay Summary Page 2 Scientific Discussion Page 4 Steps Taken for Assessment Page 11 Steps Taken After Initial Authorisation Page
More informationYoon Nofsinger, M.D. Tampa ENT Associates, 3450 East Fletcher Avenue, Tampa, FL 33613 Phone (813) 972-3353, Fax (813) 978 3667
Yoon Nofsinger, M.D. Tampa ENT Associates, 3450 East Fletcher Avenue, Tampa, FL 33613 Phone (813) 972-3353, Fax (813) 978 3667 General Information: Allergies and Injection Therapy 1. General: You have
More informationSynopsis of Causation
Ministry of Defence Synopsis of Causation Bronchial Asthma Author: Dr David Jenkins, Medical Author, Medical Text, Edinburgh Validator: Professor Stephen Holgate, Southampton General Hospital, Southampton
More informationTESTING FOR FOOD ALLERGIES. Laine Keahey, MD Arizona Allergy Associates
TESTING FOR FOOD ALLERGIES Laine Keahey, MD Arizona Allergy Associates Objectives Understand what blood tests(rast) and skin tests are measuring Learn what the size of a positive skin test really means
More informationAsthma: Practical Tips For P.E. & H.E. Teachers
Asthma: Practical Tips For P.E. & H.E. Teachers Developed and provided by: The Minnesota Department of Health Asthma Program 2004 How Many Kids Have Asthma? Approximately 2.5 students in a class of 30
More informationAsthma Care. Of course, your coach is there to answer any questions you have about your asthma, such as:
Asthma Care All Health Coaches in the Asthma Care Management program are registered or certified respiratory therapists. Your coach will listen to your story of living with asthma. This will help your
More informationAnaphylaxis: A Life Threatening Allergic Reaction
Anaphylaxis: A Life Threatening Allergic Reaction What is Anaphylaxis? Anaphylaxis is a sudden, severe, and potentially fatal allergic reaction that can cause a wide range of symptoms, including breathing
More informationinability to take a deep breath)
Algorithm for the diagnosis and management of asthma: a practice parameter update These parameters were developed by the Joint Task Force on Practice Parameters, representing the American Academy of Allergy,
More informationGestione della dermatite atopica
Gestione della dermatite atopica Peroni Diego Clinica Pediatrica di Verona Pathogenesis of atopic eczema Genes Environment Abnormal TH2 immune response to environmental allergens Skin hyperresponsiveness
More information5. Treatment of Asthma in Children
Treatment of sthma in hildren 5. Treatment of sthma in hildren 5.1 Maintenance Treatment 5.1.1 rugs Inhaled Glucocorticoids. Persistent wheezing in children under the age of three can be controlled with
More informationRise of the killer peanuts
Rise of the killer peanuts Epi Then, Epi Now Taher Vohra, MD Henry Ford Hospital Department of Emergency Medicine ObjecCves To define anaphylaxis To review the epidemiology of anaphylaxis To discuss treatments
More informationAsthma POEMs. Patient Orientated Evidence that Matters
ASTHMA POEMs Asthma POEMs Patient Orientated Evidence that Matters Developed by the Best Practice Advocacy Centre Level 8, 10 George Street PO Box 6032 Dunedin Phone 03 4775418 Fax 03 4772622 Acknowledgement
More informationHypersensitivity. TYPE I Hypersensitivity Classic allergy. Allergens. Characteristics of allergens. Allergens. Mediated by IgE attached to Mast cells.
Gel and Coombs classification of hypersensitivities. Hypersensitivity Robert Beatty Type I Type II Type III Type IV MCB150 IgE Mediated IgG/IgM Mediated IgG Mediated T cell Classic Allergy rbc lysis Immune
More informationRES/006/APR16/AR. Speaker : Dr. Pither Sandy Tulak SpP
RES/006/APR16/AR Speaker : Dr. Pither Sandy Tulak SpP Definition of Asthma (GINA 2015) Asthma is a common and potentially serious chronic disease that imposes a substantial burden on patients, their families
More informationBritish Guideline on the Management of Asthma
101 British Guideline on the Management of Asthma A national clinical guideline May 2008 revised May 2011 KEY TO EVIDENCE STATEMENTS AND GRADES OF RECOMMENDATIONS LEVELS OF EVIDENCE 1 ++ High quality meta-analyses,
More informationAsthma Intervention. An Independent Licensee of the Blue Cross and Blue Shield Association.
Asthma Intervention 1. Primary disease education Member will have an increased understanding of asthma and the classification by severity, the risks and the complications. Define asthma Explain how lungs
More informationAllergies: ENT and Allergy Center of Missouri YOUR GUIDE TO TESTING AND TREATMENT. University of Missouri Health Care
Allergies: YOUR GUIDE TO TESTING AND TREATMENT ENT and Allergy Center of Missouri University of Missouri Health Care 812 N. Keene St., Columbia, MO 65201 (573) 817-3000 www.muhealth.org WHAT CAUSES ALLERGIES
More informationHow to Manage Asthma in Children
Clinical Guideline for the Diagnosis, Evaluation and Management of Adults and Children with Asthma Color Key n Four Components of Asthma Care n Classifying Asthma Severity, Assessing Asthma Control and
More informationStandardizing the measurement of drug exposure
Standardizing the measurement of drug exposure The ability to determine drug exposure in real-world clinical practice enables important insights for the optimal use of medicines and healthcare resources.
More informationPediatric. Updated 2008
A S T H M A P R O V I D E R M A N U A L Pediatric Updated 2008 Asthma 2 Causes of Asthma 3 Utah Prevalence 3 Diagnosis 7 Managing Asthma 9 Education for Partnership in Care 11 Control of Environmental
More informationDiagnosis and treatment of asthma in childhood: a PRACTALL consensus report
Allergy 2008: 63: 5 34 Ó 2008 The Authors Journal compilation Ó 2008 Blackwell Munksgaard DOI: 10.1111/j.1398-9995.2007.01586.x Review article Diagnosis and treatment of asthma in childhood: a PRACTALL
More informationEpidemiological Studies on Environmental Stressors from Tobacco to Pesticides
Epidemiological Studies on Environmental Stressors from Tobacco to Pesticides W. Susan Cheng, PhD, MPH Rebecca Carlstrom, MPH Sukaina Hussain, MPH Healthy Lawn Symposium Oct 31, 2014 Two Presentations
More informationGEORGIA MEDICAID FEE-FOR-SERVICE ASTHMA and COPD AGENTS PA SUMMARY
GEORGIA MEDICAID FEE-FOR-SERVICE ASTHMA and COPD AGENTS PA SUMMARY Preferred Anticholinergics and Combinations Atrovent HFA (ipratropium) Combivent Respimat (ipratropium/albuterol) Ipratropium neb inhalation
More informationGet Your Head In The Game. Matthew Voorman, MD Hutchinson Clinic March 21, 2016
Get Your Head In The Game Matthew Voorman, MD Hutchinson Clinic March 21, 2016 About Me Otolaryngology Head & Neck Surgery Geisinger Medical Center General Surgery University of California San Francisco
More informationYour Go-to COPD Guide
Your Go-to COPD Guide Learning how to live with chronic obstructive pulmonary disease (COPD) Inside, you ll learn: COPD facts COPD symptoms and triggers How to talk with your doctor Different treatment
More informationTreatments for allergy are usually straightforward, safe and effective. Common treatments include:
Allergy Medications The treatments prescribed for allergy control the symptoms and reactions; they do not cure the condition. However, using treatments as prescribed can show a huge change in a patient
More informationSpirometry Workshop for Primary Care Nurse Practitioners
Spirometry Workshop for Primary Care Nurse Practitioners Catherine Casey S. Jones PhD, RN, AE-C, ANP-C Certified Adult Nurse Practitioner Texas Pulmonary & Critical Care Consultants P.A. and Visiting Assistant
More informationInterpretation of Pulmonary Function Tests
Interpretation of Pulmonary Function Tests Dr. Sally Osborne Cellular & Physiological Sciences University of British Columbia Room 3602, D.H Copp building 604 822-3421 sally.osborne@ubc.ca www.sallyosborne.com
More information